Shares in stem cell biotech Mesoblast are going nuts – Business Insider Australia
Business Insider Australia |
Shares in stem cell biotech Mesoblast are going nuts
Business Insider Australia The shares surged last month when the company announced its stem cell treatment has been found effective in helping children survive bone marrow transplants. A week before that the company said a trial of Mesoblast's stem cell product had been shown to … |
